Abstract
Cutaneous squamous cell carcinoma (SCC) is particularly problematic in certain patient groups, including patients with dystrophic or junctional epidermolysis bullosa (DEB/JEB). Theoretically, vaccination against a cell surface antigen which is expressed on this type of tumour could prevent SCC development, as well as treat primary and metastatic disease in this patient group. Preliminary studies have suggested that MUC1, a transmembrane glycoprotein, is overexpressed in sporadic cutaneous SCCs, and MUC1 has been used with some success as a target antigen for vaccine development in breast cancer, where it is expressed on > 50% of neoplastic cells in approximately 50-80% of tumours. Furthermore, aberrant glycosylation of MUC1 has been detected in this and other cancer types; however, the glycosylation status of MUC1 in cutaneous SCC is not known. To investigate the expression and glycosylation status of MUC1 in SCCs arising in patients with DEB and JEB, and for comparison in sporadic SCCs and sporadic Bowen's disease. Immunohistochemical analysis of MUC1 in 30 SCCs from subjects with DEB/JEB, 55 sporadic SCCs and 30 sporadic lesions of Bowen's disease was carried out using four separate monoclonal antibodies which recognize diffe...Continue Reading
References
Apr 1, 1992·Journal of Cutaneous Pathology·J A McGrathR A Eady
Jul 13, 1991·Lancet·B LindelöfL Molin
May 1, 1984·Histopathology·E HeydermanP H McKee
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Oct 1, 1996·Glycoconjugate Journal·J Magarian-BlanderO J Finn
Jan 1, 1997·Glycoconjugate Journal·P A PolandR P Hughey
May 29, 1997·International Journal of Cancer. Journal International Du Cancer·A BaruchD H Wreschner
Aug 12, 1998·International Journal of Cancer. Journal International Du Cancer·C A ReisM Sobrinho-Simões
May 26, 1999·Pharmacology & Therapeutics·D W Miles, J Taylor-Papadimitriou
Sep 30, 1999·International Journal of Cancer. Journal International Du Cancer·E C MommersP J van Diest
Nov 26, 1999·Biochimica Et Biophysica Acta·J Taylor-PapadimitriouM Dalziel
Sep 6, 2000·Histopathology·T W BeerJ M Theaker
Sep 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P MukherjeeS J Gendler
Dec 29, 2000·The Journal of Biological Chemistry·M DalzielJ Taylor-Papadimitriou
May 29, 2001·Journal of Clinical Pathology·R L ten BergeC J Meijer
Jun 8, 2001·Cancer·J J RahnJ C Hugh
Jun 19, 2001·Histochemistry and Cell Biology·Y Cao, U Karsten
Dec 11, 2002·Clinical and Experimental Dermatology·R Mallipeddi
Citations
Dec 1, 2009·Dermatologic Clinics·Andrew P South, Edel A O'Toole
Dec 18, 2007·Journal of Cellular and Molecular Medicine·R F SmithA A Smith
May 24, 2007·Experimental Dermatology·Ulrich RodeckJouni Uitto
Mar 16, 2013·Journal of Cutaneous Pathology·Yumi HondaKen-ichi Iyama
Jul 1, 2010·The British Journal of Dermatology·A K KivisaariV-M Kähäri
May 8, 2014·BioResearch Open Access·Priyadarsini KumarGordon C Douglas
Jul 28, 2019·Journal of Immunoassay & Immunochemistry·Asmaa Gaber AbdouMarwa Ali
May 9, 2012·Cancer Research·Yi-Zhen NgAndrew P South